Summit Therapeutics, Inc. Tech Stack
Clinical-stage biotech executing late-phase oncology trials and regulatory submissions
Summit is a public biotech firm (NASDAQ: SMMT) managing multiple phase 3 oncology studies while preparing for regulatory inspection and commercial launch. The stack leans heavily on clinical trial data management (Medidata Rave, CDISC SDTM, Veeva) and statistical analysis (R, SAS, Spotfire, Tableau), with support from enterprise resource planning (NetSuite, Coupa). Hiring skews toward director and senior roles across healthcare, research, and regulatory functions—consistent with a company scaling toward trial completion and manufacturing readiness rather than pure R&D.
Tech Stack 12 technologies
What Summit Therapeutics, Inc. Is Building
◆Challenges
- Ensuring gmp compliance
- Inspection readiness
- Broad access
- Maintaining quality and integrity of clinical trial data
- Audit compliance
- Scaling tools
- Vendor integration
- Technology transfer
- Integrating corporate software systems
- Improving onboarding processes
▲Active Projects
- Harmoni phase 3 clinical study
- Harmoni-3 phase 3 study
- Process validation for sterile drug product
- Global clinical trial applications
- Global phase 3 clinical trials
- Forecasting and revenue modeling
- Media plans for pipeline
- Inspection readiness
- Nsclc indications launch
- Clinical trial accrual and prepayment reconciliation
Hiring Activity
Department
Seniority
Notable leadership hires: Therapeutic Area Head, Clinical Operations Director, Medical Director, Regulatory Affairs Director, Key Accounts Lead
